FDAnews Device Daily Bulletin

RESPONSE BIOMEDICAL ANNOUNCES LXU HEALTHCARE AS A REGIONAL US DISTRIBUTOR FOR THE RAMP CARDIOVASCULAR TESTS

Dec. 2, 2005
A A

Response Biomedical Corp. announced today that it has appointed LXU Healthcare, Inc., a leading provider of premier medical equipment and specialty devices, as its exclusive distributor for the RAMP Cardiovascular Tests in a number of key markets in the USA. Response Biomedical has received US Food and Drug Administration (FDA) and Canadian regulatory clearance for its fluorescence-based RAMP Reader for general clinical use and three RAMP Cardiac Marker Tests for detecting

troponin I, CK-MB and myoglobin.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/12-01-2005/0004225845&EDATE=)